AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Lille
💬

In plain words

What the trial is, and whether it could suit you

WILL MANAGE is a prospective multicenter controlled open label randomized trial comparing an algorithm-based multidisciplinary management to a standard of care to reduce the incidence of bleeding (GI bleeding or severe epistaxis) recurrence in von Willebrand disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Males and females adults aged \> 18 years * With a constitutional von Willebrand Disease (according to the phenotypic criteria of the French Reference Center of von Willebrand Disease) * With a GI bleeding \[either overt (any hematemesis, any melena or hematochezia with at least a 2g/dL drop in hemoglobin) or occult (iron deficiency anemia with at least 2g/dL drop in hemoglobin)\] with the presence of angiodysplasia or a negative finding on digestive conventional endoscopy OR with a severe epistaxis (requiring red blood cells transfusion or treatment with VWF concentrates) * Be affiliated to a social security scheme * Written informed consent obtained Exclusion Criteria: * Acquired von Willebrand Disease * Presence of an inhibitor to VWF or a contra indication to VWF concentrates * Contra-indication to videocapsule endoscopy * Refusal of the procedures part of the study * Pregnant women or breastfeeding * Short-life expectancy * Liver cirrhosis Child-Pugh C or diagnosed portal hypertension * Cancer currently undergoing chemotherapy * Inability to provide informed consent * Patient under justice protection
💊

What it tests

  • Optimized management
  • Standard of care management
📍

Where

17 sites
CHU Lille
Lille, France
CHU Tours
Tours, France
CHU Amiens
Amiens, France
CHRU Brest
Brest, France
Hôpital cardiologique Louis Pradel
Bron, France
CHU Caen
Caen, France
CH Chambery
Chambéry, France
CHU Clermont-Ferrand
Clermont-Ferrand, France

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy